Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 5 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 5, no: 4 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: E9B628
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 125 | 129 | PF00656 | 0.381 |
CLV_C14_Caspase3-7 | 46 | 50 | PF00656 | 0.452 |
CLV_NRD_NRD_1 | 220 | 222 | PF00675 | 0.656 |
CLV_NRD_NRD_1 | 241 | 243 | PF00675 | 0.645 |
CLV_NRD_NRD_1 | 84 | 86 | PF00675 | 0.625 |
CLV_PCSK_FUR_1 | 239 | 243 | PF00082 | 0.480 |
CLV_PCSK_KEX2_1 | 241 | 243 | PF00082 | 0.645 |
CLV_PCSK_KEX2_1 | 84 | 86 | PF00082 | 0.612 |
CLV_PCSK_SKI1_1 | 221 | 225 | PF00082 | 0.417 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.507 |
DOC_CKS1_1 | 42 | 47 | PF01111 | 0.542 |
DOC_MAPK_RevD_3 | 207 | 222 | PF00069 | 0.333 |
DOC_PP4_FxxP_1 | 165 | 168 | PF00568 | 0.589 |
DOC_PP4_FxxP_1 | 210 | 213 | PF00568 | 0.414 |
DOC_PP4_FxxP_1 | 260 | 263 | PF00568 | 0.460 |
DOC_PP4_FxxP_1 | 42 | 45 | PF00568 | 0.510 |
DOC_PP4_FxxP_1 | 71 | 74 | PF00568 | 0.512 |
DOC_PP4_FxxP_1 | 80 | 83 | PF00568 | 0.435 |
DOC_USP7_MATH_1 | 129 | 133 | PF00917 | 0.586 |
DOC_USP7_MATH_1 | 234 | 238 | PF00917 | 0.722 |
DOC_WW_Pin1_4 | 109 | 114 | PF00397 | 0.619 |
DOC_WW_Pin1_4 | 41 | 46 | PF00397 | 0.514 |
LIG_14-3-3_CanoR_1 | 122 | 131 | PF00244 | 0.399 |
LIG_14-3-3_CanoR_1 | 23 | 31 | PF00244 | 0.525 |
LIG_14-3-3_CanoR_1 | 241 | 251 | PF00244 | 0.690 |
LIG_14-3-3_CanoR_1 | 85 | 95 | PF00244 | 0.596 |
LIG_Actin_WH2_2 | 205 | 223 | PF00022 | 0.514 |
LIG_Clathr_ClatBox_1 | 192 | 196 | PF01394 | 0.517 |
LIG_eIF4E_1 | 109 | 115 | PF01652 | 0.584 |
LIG_FHA_1 | 110 | 116 | PF00498 | 0.567 |
LIG_FHA_1 | 215 | 221 | PF00498 | 0.560 |
LIG_FHA_1 | 246 | 252 | PF00498 | 0.657 |
LIG_FHA_1 | 25 | 31 | PF00498 | 0.511 |
LIG_FHA_1 | 254 | 260 | PF00498 | 0.442 |
LIG_FHA_2 | 123 | 129 | PF00498 | 0.542 |
LIG_FHA_2 | 175 | 181 | PF00498 | 0.680 |
LIG_LIR_Apic_2 | 154 | 160 | PF02991 | 0.626 |
LIG_LIR_Apic_2 | 208 | 213 | PF02991 | 0.444 |
LIG_LIR_Apic_2 | 258 | 263 | PF02991 | 0.475 |
LIG_LIR_Nem_3 | 194 | 200 | PF02991 | 0.407 |
LIG_PCNA_PIPBox_1 | 1 | 10 | PF02747 | 0.596 |
LIG_Pex14_1 | 186 | 190 | PF04695 | 0.624 |
LIG_Pex14_2 | 260 | 264 | PF04695 | 0.522 |
LIG_SH2_CRK | 190 | 194 | PF00017 | 0.495 |
LIG_SH2_NCK_1 | 157 | 161 | PF00017 | 0.645 |
LIG_SH2_NCK_1 | 190 | 194 | PF00017 | 0.312 |
LIG_SH2_SRC | 157 | 160 | PF00017 | 0.617 |
LIG_SH2_SRC | 72 | 75 | PF00017 | 0.434 |
LIG_SH2_STAT5 | 120 | 123 | PF00017 | 0.500 |
LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.585 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.468 |
LIG_SH2_STAT5 | 86 | 89 | PF00017 | 0.526 |
LIG_SH3_3 | 244 | 250 | PF00018 | 0.426 |
LIG_SUMO_SIM_par_1 | 191 | 196 | PF11976 | 0.397 |
LIG_SUMO_SIM_par_1 | 248 | 256 | PF11976 | 0.566 |
LIG_TRAF2_1 | 230 | 233 | PF00917 | 0.643 |
LIG_TYR_ITIM | 188 | 193 | PF00017 | 0.323 |
MOD_CK1_1 | 142 | 148 | PF00069 | 0.594 |
MOD_CK1_1 | 150 | 156 | PF00069 | 0.671 |
MOD_CK1_1 | 225 | 231 | PF00069 | 0.685 |
MOD_CK1_1 | 245 | 251 | PF00069 | 0.400 |
MOD_CK1_1 | 90 | 96 | PF00069 | 0.549 |
MOD_CK2_1 | 101 | 107 | PF00069 | 0.442 |
MOD_CK2_1 | 142 | 148 | PF00069 | 0.594 |
MOD_CK2_1 | 174 | 180 | PF00069 | 0.594 |
MOD_CK2_1 | 86 | 92 | PF00069 | 0.605 |
MOD_GlcNHglycan | 103 | 106 | PF01048 | 0.467 |
MOD_GlcNHglycan | 140 | 144 | PF01048 | 0.551 |
MOD_GlcNHglycan | 225 | 228 | PF01048 | 0.615 |
MOD_GlcNHglycan | 236 | 239 | PF01048 | 0.677 |
MOD_GlcNHglycan | 244 | 247 | PF01048 | 0.620 |
MOD_GlcNHglycan | 45 | 48 | PF01048 | 0.662 |
MOD_GSK3_1 | 174 | 181 | PF00069 | 0.645 |
MOD_GSK3_1 | 221 | 228 | PF00069 | 0.635 |
MOD_GSK3_1 | 241 | 248 | PF00069 | 0.698 |
MOD_GSK3_1 | 86 | 93 | PF00069 | 0.593 |
MOD_N-GLC_1 | 122 | 127 | PF02516 | 0.478 |
MOD_N-GLC_1 | 234 | 239 | PF02516 | 0.626 |
MOD_N-GLC_1 | 268 | 273 | PF02516 | 0.687 |
MOD_NEK2_1 | 139 | 144 | PF00069 | 0.541 |
MOD_NEK2_1 | 173 | 178 | PF00069 | 0.603 |
MOD_PKA_1 | 221 | 227 | PF00069 | 0.596 |
MOD_PKA_1 | 241 | 247 | PF00069 | 0.463 |
MOD_PKA_1 | 84 | 90 | PF00069 | 0.627 |
MOD_PKA_2 | 101 | 107 | PF00069 | 0.292 |
MOD_PKA_2 | 121 | 127 | PF00069 | 0.283 |
MOD_PKA_2 | 241 | 247 | PF00069 | 0.546 |
MOD_PKA_2 | 25 | 31 | PF00069 | 0.534 |
MOD_PKA_2 | 84 | 90 | PF00069 | 0.613 |
MOD_PKB_1 | 239 | 247 | PF00069 | 0.643 |
MOD_Plk_1 | 115 | 121 | PF00069 | 0.448 |
MOD_Plk_1 | 153 | 159 | PF00069 | 0.633 |
MOD_Plk_2-3 | 191 | 197 | PF00069 | 0.508 |
MOD_Plk_2-3 | 253 | 259 | PF00069 | 0.491 |
MOD_Plk_4 | 115 | 121 | PF00069 | 0.519 |
MOD_Plk_4 | 214 | 220 | PF00069 | 0.408 |
MOD_Plk_4 | 25 | 31 | PF00069 | 0.418 |
MOD_Plk_4 | 90 | 96 | PF00069 | 0.489 |
MOD_ProDKin_1 | 109 | 115 | PF00069 | 0.608 |
MOD_ProDKin_1 | 41 | 47 | PF00069 | 0.528 |
TRG_DiLeu_BaLyEn_6 | 247 | 252 | PF01217 | 0.579 |
TRG_ENDOCYTIC_2 | 190 | 193 | PF00928 | 0.486 |
TRG_ER_diArg_1 | 64 | 67 | PF00400 | 0.569 |
TRG_ER_diArg_1 | 83 | 85 | PF00400 | 0.292 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I5Y1 | Leptomonas seymouri | 52% | 75% |
A0A0S4JB49 | Bodo saltans | 29% | 90% |
A0A1X0P5P8 | Trypanosomatidae | 30% | 90% |
A0A3Q8IHV2 | Leishmania donovani | 89% | 96% |
A0A3R7LR32 | Trypanosoma rangeli | 33% | 90% |
A4HMH1 | Leishmania braziliensis | 73% | 100% |
A4IB51 | Leishmania infantum | 89% | 71% |
C9ZZF6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 87% |